colistimethate sodium has been researched along with carbapenems in 5 studies
Studies (colistimethate sodium) | Trials (colistimethate sodium) | Recent Studies (post-2010) (colistimethate sodium) | Studies (carbapenems) | Trials (carbapenems) | Recent Studies (post-2010) (carbapenems) |
---|---|---|---|---|---|
188 | 12 | 140 | 7,355 | 147 | 5,277 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Corbella, X; Corral, L; Fernandez-Viladrich, P; Mateu, A; Tubau, F | 1 |
Cacciarelli, TV; Muder, RR; Shields, RK; Singh, N; Sun, HY | 1 |
Bonomo, RA; Endimiani, A; Fraser, TG; Hall, GS; Neuner, EA; Sekeres, J; Shrestha, NK; van Duin, D; Yeh, JY | 1 |
Chen, CC; Chen, CH; Chiang, SR; Chuang, YC; Ko, WC; Lee, NY; Shieh, JM; Tang, HJ | 1 |
Abad, CLR; Li, KL | 1 |
5 other study(ies) available for colistimethate sodium and carbapenems
Article | Year |
---|---|
Successful treatment of ventriculitis due to carbapenem-resistant Acinetobacter baumannii with intraventricular colistin sulfomethate sodium.
Topics: Acinetobacter; Acinetobacter Infections; Adolescent; Adult; Anti-Bacterial Agents; Brain Diseases; Carbapenems; Central Nervous System Bacterial Infections; Cerebral Ventricles; Colistin; Drug Resistance, Microbial; Encephalitis; Female; Humans; Injections, Intraventricular; Male; Middle Aged; Treatment Outcome | 1999 |
A novel combination regimen for the treatment of refractory bacteremia due to multidrug-resistant Pseudomonas aeruginosa in a liver transplant recipient.
Topics: Anti-Bacterial Agents; Bacteremia; Bile Duct Diseases; Carbapenems; Colistin; Doripenem; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Humans; Liver Transplantation; Male; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin; Treatment Outcome | 2010 |
Treatment and outcomes in carbapenem-resistant Klebsiella pneumoniae bloodstream infections.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Minocycline; Prognosis; Retrospective Studies; Tigecycline; Treatment Outcome | 2011 |
Comparative evaluation of intratracheal colistimethate sodium, imipenem, and meropenem in BALB/c mice with carbapenem-resistant Acinetobacter baumannii pneumonia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Acute Disease; Animals; Anti-Bacterial Agents; Carbapenems; Cilastatin; Cilastatin, Imipenem Drug Combination; Colistin; Cytokines; Disease Models, Animal; Drug Combinations; Drug Resistance, Bacterial; Female; Imipenem; Meropenem; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Pneumonia, Bacterial; Stem Cells; Thienamycins | 2012 |
The clinical profile and outcomes of adult patients given intravenous colistin for multidrug-resistant gram negative infections in a Philippine tertiary hospital.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Administration, Intravenous; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Gram-Negative Bacterial Infections; Hospitalization; Humans; Male; Meropenem; Middle Aged; Organ Dysfunction Scores; Philippines; Respiratory Tract Infections; Retrospective Studies; Tertiary Care Centers; Treatment Outcome; Young Adult | 2020 |